80 related articles for article (PubMed ID: 14673516)
1. Two-dimensional gel electrophoresis analysis of the abundance of virulent exoproteins of group A streptococcus caused by environmental changes.
Nakamura T; Hasegawa T; Torii K; Hasegawa Y; Shimokata K; Ohta M
Arch Microbiol; 2004 Jan; 181(1):74-81. PubMed ID: 14673516
[TBL] [Abstract][Full Text] [Related]
2. Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis.
Tanaka M; Hasegawa T; Okamoto A; Torii K; Ohta M
Antimicrob Agents Chemother; 2005 Jan; 49(1):88-96. PubMed ID: 15616280
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
Woischnik M; Buttaro BA; Podbielski A
Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
[TBL] [Abstract][Full Text] [Related]
4. Role of group A Streptococcus HtrA in the maturation of SpeB protease.
Cole JN; Aquilina JA; Hains PG; Henningham A; Sriprakash KS; Caparon MG; Nizet V; Kotb M; Cordwell SJ; Djordjevic SP; Walker MJ
Proteomics; 2007 Dec; 7(24):4488-98. PubMed ID: 18072207
[TBL] [Abstract][Full Text] [Related]
5. Superantigens SPEA and SMEZ do not affect secretome expression in Streptococcus pyogenes.
Russell HH; Sriskandan S
Microb Pathog; 2008 Jun; 44(6):537-43. PubMed ID: 18329243
[TBL] [Abstract][Full Text] [Related]
6. From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production.
Carroll RK; Musser JM
Mol Microbiol; 2011 Aug; 81(3):588-601. PubMed ID: 21707787
[TBL] [Abstract][Full Text] [Related]
7. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
[TBL] [Abstract][Full Text] [Related]
8. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.
Sawai J; Hasegawa T; Kamimura T; Okamoto A; Ohmori D; Nosaka N; Yamada K; Torii K; Ohta M
Antimicrob Agents Chemother; 2007 Feb; 51(2):461-7. PubMed ID: 17101685
[TBL] [Abstract][Full Text] [Related]
9. Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva.
Shelburne SA; Granville C; Tokuyama M; Sitkiewicz I; Patel P; Musser JM
Infect Immun; 2005 Aug; 73(8):4723-31. PubMed ID: 16040985
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the group A Streptococcus regulator srv results in chromosome wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB.
Reid SD; Chaussee MS; Doern CD; Chaussee MA; Montgomery AG; Sturdevant DE; Musser JM
FEMS Immunol Med Microbiol; 2006 Nov; 48(2):283-92. PubMed ID: 16999824
[TBL] [Abstract][Full Text] [Related]
11. Properties of metabolic substances produced by group A streptococcus from a food-borne epidemic.
Kanno T; Sakaguchi K; Fukuyama M; Suzuki J
J Infect Chemother; 2011 Aug; 17(4):462-7. PubMed ID: 21190121
[TBL] [Abstract][Full Text] [Related]
12. Time course of virulence factors produced by group A streptococcus during a food-borne epidemic.
Kanno T; Sakaguchi K; Suzuki J
J Infect Chemother; 2012 Feb; 18(1):35-40. PubMed ID: 21750972
[TBL] [Abstract][Full Text] [Related]
13. Environmental pH changes, but not the LuxS signalling pathway, regulate SpeB expression in M1 group A streptococci.
Chiang-Ni C; Zheng PX; Tsai PJ; Chuang WJ; Lin YS; Liu CC; Wu JJ
J Med Microbiol; 2012 Jan; 61(Pt 1):16-22. PubMed ID: 21890514
[TBL] [Abstract][Full Text] [Related]
14. The M protein is dispensable for maturation of streptococcal cysteine protease SpeB.
Zimmerlein B; Park HS; Li S; Podbielski A; Cleary PP
Infect Immun; 2005 Feb; 73(2):859-64. PubMed ID: 15664926
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule.
Mangold M; Siller M; Roppenser B; Vlaminckx BJ; Penfound TA; Klein R; Novak R; Novick RP; Charpentier E
Mol Microbiol; 2004 Sep; 53(5):1515-27. PubMed ID: 15387826
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection.
Kuo CF; Luo YH; Lin HY; Huang KJ; Wu JJ; Lei HY; Lin MT; Chuang WJ; Liu CC; Jin YT; Lin YS
Microb Pathog; 2004 May; 36(5):273-85. PubMed ID: 15043862
[TBL] [Abstract][Full Text] [Related]
17. Streptococcal pyrogenic exotoxin B cleaves human S-adenosylhomocysteine hydrolase and induces hypermethioninemia.
Hsu JF; Chuang WJ; Shiesh SC; Lin YS; Liu CC; Wang CC; Fu TF; Tsai JH; Tsai WL; Huang YJ; Hsieh YH; Wu JJ; Lin MT; Huang W
J Infect Dis; 2008 Aug; 198(3):367-74. PubMed ID: 18522500
[TBL] [Abstract][Full Text] [Related]
18. Streptococcal pyogenic exotoxin B (SpeB) boosts the contact system via binding of α-1 antitrypsin.
Meinert Niclasen L; Olsen JG; Dagil R; Qing Z; Sørensen OE; Kragelund BB
Biochem J; 2011 Feb; 434(1):123-32. PubMed ID: 21080914
[TBL] [Abstract][Full Text] [Related]
19. SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes.
Kagawa TF; O'toole PW; Cooney JC
Mol Microbiol; 2005 Aug; 57(3):650-66. PubMed ID: 16045611
[TBL] [Abstract][Full Text] [Related]
20. Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products.
Saouda M; Wu W; Conran P; Boyle MD
J Infect Dis; 2001 Sep; 184(6):723-31. PubMed ID: 11517433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
